We are live on ! Find out more
FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.89B
1-Year Est. Return 201.1%
This Fund
S&P 500
This Quarter Est. Return
+29.57%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$310M
Cap. Flow
+$124M
Cap. Flow %
7.72%
Top 10 Hldgs %
66.37%
Holding
50
New
7
Increased
9
Reduced
5
Closed
6

Top Buys

1
NAMS icon
NewAmsterdam Pharma
NAMS
+$92.8M
2
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$25.4M
3
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$10.7M
4
VRNA
Verona Pharma
VRNA
+$9.54M
5
KALV
KalVista Pharmaceuticals
KALV
+$8.93M

Top Sells

1
TCDA
Tricida, Inc. Common Stock
TCDA
+$26.7M
2
FLACU
Frazier Lifesciences Acquisition Corporation Unit
FLACU
+$15.2M
3
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
+$9.31M
4
PCVX icon
Vaxcyte
PCVX
+$5.89M
5
MGNX icon
MacroGenics
MGNX
+$2.43M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERE
26
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$12.4M 0.77%
393,000
– –
MRUS
27
DELISTED
Merus
MRUS
$11.5M 0.72%
746,479
– –
VECT
28
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$11.5M 0.71%
+1,333,400
New +$10.7M
RNAM
29
DELISTED
Avidity Biosciences
RNAM
$11.1M 0.69%
+500,000
New +$7.46M
IMVT icon
30
Immunovant
IMVT
$8B
$10.4M 0.65%
585,759
– –
TYRA icon
31
Tyra Biosciences
TYRA
$1.88B
$10.1M 0.63%
1,327,665
– –
BLUE
32
DELISTED
bluebird bio
BLUE
$9.97M 0.62%
72,038
– –
ARVN icon
33
Arvinas
ARVN
$518M
$9.76M 0.61%
285,331
– –
PRTA icon
34
Prothena Corp
PRTA
$443M
$7.71M 0.48%
+127,900
New +$7.49M
AUTL
35
Autolus Therapeutics
AUTL
$389M
$7.12M 0.44%
3,746,857
– –
NTLA icon
36
Intellia Therapeutics
NTLA
$1.66B
$7.11M 0.44%
203,684
– –
THRX
37
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$6.96M 0.43%
+1,398,194
New +$8.19M
PASG icon
38
Passage Bio
PASG
$15.8M
$5.18M 0.32%
187,846
– –
ZYME icon
39
Zymeworks
ZYME
$1.78B
$4.79M 0.3%
+610,000
New +$4.29M
ACRS icon
40
Aclaris Therapeutics
ACRS
$749M
$4.57M 0.28%
290,189
-118,140
-29% -$1.9M
EPIX
41
DELISTED
ESSA Pharma
EPIX
$1.52M 0.09%
605,141
-87,769
-13% -$252K
APTX
42
DELISTED
Aptinyx Inc. Common Stock
APTX
$537K 0.03%
1,883,244
– –
NAMSW icon
43
NewAmsterdam Pharma Warrant
NAMSW
$94.6M
$434K 0.03%
+500,333
New +$412K
NBRV
44
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$32.2K ﹤0.01%
17,025
– –
MGNX icon
45
MacroGenics
MGNX
$262M
– –
-701,631
Closed -$2.43M
GRCL
46
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-2,890,102
Closed -$9.31M
PRDS
47
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-845,636
Closed -$1.56M
MTEM
48
DELISTED
Molecular Templates, Inc.
MTEM
– –
-91,603
Closed -$1.03M
TCDA
49
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-2,549,671
Closed -$26.7M
FLACU
50
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
– –
-1,501,000
Closed -$15.2M
1
2

Similar funds

GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return